Construction Partners enters June with fresh analyst coverage and a stock under pressure — a combination that sets up an interesting read on where conviction actually sits.
The week's standout event arrived this morning: Truist Securities initiated coverage with a Hold rating and a $130 price target. That's below the current Baird Outperform target of $169, raised sharply in May from $129 following the May 8 earnings beat. The coverage split now captures the tension on the stock well. Baird's aggressive lift was clearly earnings-driven; Truist's cautious entry, with the stock trading at $111.43, implies roughly 16% upside to its target but carries none of the conviction. With only one firm officially rated in the consensus data and a mean target of $150, the Street picture is thin but directionally split between a cautious initiation and a more bullish post-earnings reset.
The bull and bear cases that analysts debate are well-defined. On the positive side, a $3.09 billion backlog, rising fiscal 2026-27 estimates, and accelerating infrastructure lettings — particularly in Florida — give the business real near-term visibility. Bears point to the structural risk in an acquisitions-driven growth model and the sensitivity of public contracting budgets to any slowdown in government spending. Valuation is not cheap: the trailing P/E runs at 33x and EV/EBITDA at 13.3x, with both multiples compressing over the past month as the share price fell. The P/B of 5.2x reflects the premium the market still assigns to ROAD's growth runway, even as the stock has shed nearly 12% over the past month to close at $111.43.
Short positioning tells a moderately cautious but not alarming story. Short interest has actually eased — down 5.6% on the week and 14.8% over the past month to 5.3% of the free float. That's a meaningful unwind from the late-April peak, when around 2.99 million shares were borrowed compared to today's 2.54 million. Borrow costs are low at 0.46% annually, barely changed on the week, and availability is loose at roughly 500% — meaning five times as many shares remain available to lend as are currently borrowed. The ORTEX short score of 47.9 sits squarely in neutral territory. None of this paints a picture of aggressive short-side conviction; the bears are trimming, not pressing.
Options positioning has shifted notably. The put/call ratio has collapsed to 0.74 from a range of 5.4-5.9 that dominated from late April through early May — one of the most dramatic reversals in recent sentiment data. For much of April, options traders were piling into puts at a ratio well above five-to-one. That extreme defensive posture has essentially unwound, and the PCR now runs well below its 20-day mean of 2.01 at a z-score of -0.81. The reversal coincides with the May 8 earnings print, which delivered a 3.1% next-day gain, though the stock then gave back ground over the following five days, down 10.1%. The options market has moved from deeply defensive to mildly bullish — a significant shift in tone, even if the price hasn't followed through yet.
FMR (Fidelity) remains the dominant institutional holder with 12.6% of shares, having added 2.5 million shares as of March 31. BlackRock and SunTx Capital Partners each hold around 6.6%, though SunTx's position has been unchanged since January. The most recent insider activity on record is from November 2025 — a coordinated round of sales by the CEO, three SVPs, and a related party at prices around $112, essentially where the stock trades today. That the stock has gone nowhere in seven months despite an earnings beat and backlog growth is a data point worth noting, even without drawing conclusions.
The next scheduled earnings release is August 7. Between now and then, the question is whether Truist's cautious entry attracts company on the Hold side of the ledger — or whether the backlog and estimate-revision momentum keep the bulls in control of the narrative.
See the live data behind this article on ORTEX.
Open ROAD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
